Clinical and immunological responses in sheep after inoculation with Himar1-transformed Anaplasma phagocytophilum and subsequent challenge with a virulent strain of the bacterium.

[1]  P. Wilhelmsson,et al.  Assessing the clinical and bacteriological outcomes of vaccination with recombinant Asp14 and OmpA against A. phagocytophilum in sheep. , 2019, Veterinary immunology and immunopathology.

[2]  Z. Khumalo,et al.  Evidence confirming the phylogenetic position of Anaplasma centrale (ex Theiler 1911) Ristic and Kreier 1984. , 2018, International journal of systematic and evolutionary microbiology.

[3]  S. Wikel.  Ticks and Tick-Borne Infections: Complex Ecology, Agents, and Host Interactions , 2018, Veterinary sciences.

[4]  J. Dumler,et al.  Genome-Wide Anaplasma phagocytophilum AnkA-DNA Interactions Are Enriched in Intergenic Regions and Gene Promoters and Correlate with Infection-Induced Differential Gene Expression , 2016, Front. Cell. Infect. Microbiol..

[5]  R. Ganta,et al.  Vaccination with an Attenuated Mutant of Ehrlichia chaffeensis Induces Pathogen-Specific CD4+ T Cell Immunity and Protection from Tick-Transmitted Wild-Type Challenge in the Canine Host , 2016, PloS one.

[6]  R. Felsheim,et al.  An O-Methyltransferase Is Required for Infection of Tick Cells by Anaplasma phagocytophilum , 2015, PLoS pathogens.

[7]  A. Matussek,et al.  Detection of Anaplasma phagocytophilum in Ixodes ricinus ticks from Norway using a realtime PCR assay targeting the Anaplasma citrate synthase gene gltA , 2015, BMC Microbiology.

[8]  A. Barbet,et al.  Lambs immunized with an inactivated variant of Anaplasma phagocytophilum , 2015, Acta Veterinaria Scandinavica.

[9]  J. Turse,et al.  Subdominant Outer Membrane Antigens in Anaplasma marginale: Conservation, Antigenicity, and Protective Capacity Using Recombinant Protein , 2015, PloS one.

[10]  U. Munderloh,et al.  Reduced Infectivity in Cattle for an Outer Membrane Protein Mutant of Anaplasma marginale , 2015, Applied and Environmental Microbiology.

[11]  U. Munderloh,et al.  Knockout of an outer membrane protein operon of Anaplasma marginale by transposon mutagenesis , 2014, BMC Genomics.

[12]  A. Radford,et al.  Expression of p44 variant-specific antibodies in sheep persistently infected with Anaplasma phagocytophilum. , 2013, Veterinary microbiology.

[13]  A. Espenes,et al.  Characterization of NCR1+ cells residing in lymphoid tissues in the gut of lambs indicates that the majority are NK cells , 2013, Veterinary Research.

[14]  R. Felsheim,et al.  Correction: Targeted and Random Mutagenesis of Ehrlichia chaffeensis for the Identification of Genes Required for In vivo Infection , 2013, PLoS Pathogens.

[15]  K. Artursson,et al.  Prophylactic treatment with flumethrin, a pyrethroid (Bayticol®, Bayer), against Anaplasma phagocytophilum infection in lambs , 2012, Acta Veterinaria Scandinavica.

[16]  M. Muñoz-López,et al.  DNA Transposons: Nature and Applications in Genomics , 2010, Current genomics.

[17]  A. Kalia,et al.  Functional diversity of ankyrin repeats in microbial proteins. , 2010, Trends in microbiology.

[18]  A. Alleman,et al.  Variant-specific and diminishing immune responses towards the highly variable MSP2(P44) outer membrane protein of Anaplasma phagocytophilum during persistent infection in lambs. , 2010, Veterinary immunology and immunopathology.

[19]  R. Felsheim,et al.  Transformation of Anaplasma marginale , 2010, Veterinary parasitology.

[20]  K. Bergström,et al.  Superinfection occurs in Anaplasma phagocytophilum infected sheep irrespective of infection phase and protection status , 2009, Acta veterinaria Scandinavica.

[21]  J. Hoorfar,et al.  Diagnostic PCR: comparative sensitivity of four probe chemistries. , 2009, Molecular and cellular probes.

[22]  I. Olsen,et al.  Neutralization of Interleukin-10 from CD14+ Monocytes Enhances Gamma Interferon Production in Peripheral Blood Mononuclear Cells from Mycobacterium avium subsp. paratuberculosis-Infected Goats , 2009, Clinical and Vaccine Immunology.

[23]  J. Dumler,et al.  Silencing of Host Cell CYBB Gene Expression by the Nuclear Effector AnkA of the Intracellular Pathogen Anaplasma phagocytophilum , 2009, Infection and Immunity.

[24]  C. Bogdan,et al.  The elimination of Anaplasma phagocytophilum requires CD4+ T cells, but is independent of Th1 cytokines and a wide spectrum of effector mechanisms , 2008, European journal of immunology.

[25]  H. Schweizer,et al.  In Vivo Himar1 Transposon Mutagenesis of Burkholderia pseudomallei , 2008, Applied and Environmental Microbiology.

[26]  R. Birtles,et al.  Dynamic Transmission of Numerous Anaplasma phagocytophilum Genotypes among Lambs in an Infected Sheep Flock in an Area of Anaplasmosis Endemicity , 2008, Journal of Clinical Microbiology.

[27]  R. Birtles,et al.  High-Resolution Genetic Fingerprinting of European Strains of Anaplasma phagocytophilum by Use of Multilocus Variable-Number Tandem-Repeat Analysis , 2007, Journal of Clinical Microbiology.

[28]  R. Felsheim,et al.  Transformation of Anaplasma phagocytophilum , 2006, BMC biotechnology.

[29]  J. Foley,et al.  Structure of the Expression Site Reveals Global Diversity in MSP2 (P44) Variants in Anaplasma phagocytophilum , 2006, Infection and Immunity.

[30]  Jonathan Crabtree,et al.  Comparative Genomics of Emerging Human Ehrlichiosis Agents , 2006, PLoS genetics.

[31]  Aric N. Rogers,et al.  γδ T Cell Function Varies with the Expressed WC1 Coreceptor 1 , 2005, The Journal of Immunology.

[32]  J. Dumler,et al.  Anaplasma phagocytophilum AnkA binds to granulocyte DNA and nuclear proteins , 2004, Cellular microbiology.

[33]  J. Dumler,et al.  Anaplasma phagocytophilum major surface protein-2 (Msp2) forms multimeric complexes in the bacterial membrane. , 2003, FEMS microbiology letters.

[34]  A. Storset,et al.  Modulation of leukocyte populations and immune responses in sheep experimentally infected with Anaplasma (formerly Ehrlichia) phagocytophilum. , 2003, Veterinary immunology and immunopathology.

[35]  L. Schouls,et al.  Differences in Clinical Manifestations and Hematological and Serological Responses after Experimental Infection with Genetic Variants of Anaplasma phagocytophilum in Sheep , 2003, Clinical Diagnostic Laboratory Immunology.

[36]  S. Edwards,et al.  Cultivation of an ovine strain of Ehrlichia phagocytophila in tick cell cultures. , 2002, Journal of comparative pathology.

[37]  L. Schouls,et al.  Identification of Anaplasma phagocytophila (Formerly Ehrlichia phagocytophila) Variants in Blood from Sheep in Norway , 2002, Journal of Clinical Microbiology.

[38]  G. Palmer,et al.  Detection of the Anaplasma centrale vaccine strain and specific differentiation from Anaplasma marginale in vaccinated and infected cattle , 2002, Parasitology Research.

[39]  R. Bock,et al.  Immunity following use of Australian tick fever vaccine: a review of the evidence. , 2001, Australian veterinary journal.

[40]  K. Bergström,et al.  The Effect of Two Different Oxytetracycline Treatments in Experimental Ehrlichia phagocytophila Infected Lambs , 2001, Acta veterinaria Scandinavica.

[41]  K. Bergström,et al.  Persistence of Granulocytic Ehrlichia Infection During Wintertime in Two Sheep Flocks in Norway , 2001, Acta veterinaria Scandinavica.

[42]  K. Bergström,et al.  Serological Investigation of Granulocytic Ehrlichia Infection in Sheep in Norway , 2001, Acta veterinaria Scandinavica.

[43]  X. Nassif,et al.  Mutagenesis of Neisseria meningitidis by In Vitro Transposition of Himar1 mariner , 2000, Journal of bacteriology.

[44]  K. Artursson,et al.  Effects of the dose of Ehrlichiaphagocytophila on the severit of experimental infections in lambs , 2000, Veterinary Record.

[45]  E. Engvall,et al.  A serological and clinical follow-up in horses with confirmed equine granulocytic ehrlichiosis. , 1999, Equine veterinary journal.

[46]  J. Mekalanos,et al.  Hyperactive transposase mutants of the Himar1 mariner transposon. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[47]  J. L. Goodman,et al.  Invasion and Intracellular Development of the Human Granulocytic Ehrlichiosis Agent in Tick Cell Culture , 1999, Journal of Clinical Microbiology.

[48]  E. Breitschwerdt,et al.  A retrospective study of ehrlichiosis in 62 dogs from North Carolina and Virginia. , 1999, Journal of veterinary internal medicine.

[49]  E. Engvall,et al.  Experimental Infection of Lambs with an Equine Granulocytic Ehrlichia Species Resembling the Agent that Causes Human Granulocytic Ehrlichiosis (HGE) , 1998, Acta Veterinaria Scandinavica.

[50]  N. Ogden,et al.  Granulocytic ehrlichiosis: an emerging or rediscovered tick-borne disease? , 1998, Journal of medical microbiology.

[51]  E. Fikrig,et al.  Immunization against the agent of human granulocytic ehrlichiosis in a murine model. , 1997, The Journal of clinical investigation.

[52]  M. Churchill,et al.  A purified mariner transposase is sufficient to mediate transposition in vitro , 1996, The EMBO journal.

[53]  M K Viljanen,et al.  Primers are decisive for sensitivity of PCR. , 1994, BioTechniques.

[54]  Z. Woldehiwet.  Lymphocyte subpopulations in peripheral blood of sheep experimentally infected with tick-borne fever. , 1991, Research in veterinary science.

[55]  J. Macleod,et al.  Studies in Tick-borne Fever of Sheep. I. Transmission by the Tick, Ixodes ricinus, with a Description of the Disease Produced , 1933, Parasitology.

[56]  F. Jongejan,et al.  Evidence for the Utility of the Bm86 Antigen from Boophilus Microplus in Vaccination Against Other Tick Species , 2004, Experimental & Applied Acarology.

[57]  E. Palmer,et al.  Reduced Weight Gain Due to Subclinical Anaplasma phagocytophilum (Formerly Ehrlichia phagocytophila) Infection , 2004, Experimental & Applied Acarology.

[58]  A. Foggie.  Studies on the infectious agent of tick-borne fever in sheep. , 1951, The Journal of pathology and bacteriology.

[59]  J. Hudson.  The Recognition of Tick-Borne Fever as a Disease of Cattle , 1950 .